Join experts from our Breast DSWG to review the SOUND trial design, data and impact, focusing on the multidisciplinary challenges in implementation of this data into clinical care.

The faculty for this activity are listed below:

Laura S. Dominici, MD (Planner/Moderator)
Brigham and Women's Hospital/Dana Farber Cancer Institute 

Tammy K. Neblock-Berine, MD (Planner/Moderator)
Saint Luke's Cancer Institute 

Taiwo Adesoyo, MD, MPH (Faculty)
MD Anderson Cancer Center 

Giacomo Montagna, MD, MPH (Faculty)
Memorial Sloan Kettering Cancer Center 

Jennifer R. Bellon, MD (Faculty)
Brigham and Women's Hospital/Dana Farber Cancer Institute

Rachel L. Yung, MD (Faculty)
Fred Hutchinson Cancer Center

This activity is intended for all surgeons and other health care professionals who are involved in the treatment of patients with Breast cancer.

At the conclusion of this activity, participants should be able to:

• Identify appropriate patient population in whom nodal surgery can be omitted using SOUND trial data
• Examine multidisciplinary factors that impact appropriateness of applying SOUND trial data
• Propose criteria for implementing SOUND at their institutions 

The Society of Surgical Oncology (SSO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Society of Surgical Oncology designates this internet live course for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity consists of educational content and an evaluation. Learners must view the activity content and complete the post-activity evaluation. A certificate of credit or participation will be available upon successful submission of the post-activity evaluation.

The estimated time to complete this entire activity is 1 hour.

Release Date

           November 5, 2024

CME Expiration Date

           November 5, 2025

As required by the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all planners, reviewers, presenters, instructors, moderators, authors, and other individuals in a position to control or influence the content of an activity must disclose ALL financial relationships with any ineligible company that have occurred within the past 24 months. Ineligible companies are those that cannot be accredited in the ACCME System and whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

As the accredited provider, SSO is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships of any dollar amount are defined as relevant if the educational content is related to the business lines or products of the ineligible company.

All identified conflicts of interest must be mitigated, and the educational content vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. If you perceive bias while participating in this activity, please advise us of the circumstances when completing your postactivity evaluation form.

All identified conflicts of interests have been mitigated.

Faculty

Laura Dominici, MD (Planner/Moderator) has disclosed no financial relationships.

Tammy Neblock-Beirne (Planner/Moderator) has disclosed no financial relationships.

Taiwo Adesoye, MD, MPH (Presenter) has disclosed no financial relationships.

Giacomo Montagna, MD, MPH (Presenter) has disclosed no financial relationships.

Jennifer R. Bellon, MD (Presenter) has disclosed the following financial relationships: Varian, UpToDate.

Rachel L. Yung, MD (Presenter) has disclosed the following financial relationship: Pfizer

Planners, Reviewers, and Staff

Julie Lang, MD, CME Committee Reviewer, has disclosed no financial relationships.

Lynn Dengel, MD, CME Committee Reviewer, has disclosed no financial relationships.

Patti Stella, CAE, CHCP, Society of Surgical Oncology, has disclosed the following financial relationships - Horizon Therapeutics, SODR Biotech (XBI).

Meagan Gilliland-Johnson, Society of Surgical Oncology, has disclosed no financial relationships.

Devin Winkler, Society of Surgical Oncology, has disclosed no financial relationships.

Cara Roth, Society of Surgical Oncology, has disclosed no financial relationships.

The primary purpose of the Society of Surgical Oncology's internet live course is educational. Information, as well as technologies, products, and/or services, discussed are intended to inform participants about the knowledge, techniques, and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exists in the specialty, and the Society of Surgical Oncology disclaims any and all liability for damages to any individual using the materials and for all claims which may result from the use of information, technologies, products, and/or services discussed.

This educational activity may include discussions of unlabeled/unapproved uses of drugs or devices. Participants are advised to refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Opinions expressed in this educational activity are those of the expert contributors and do not necessarily represent the views of the Society of Surgical Oncology or any other organization associated with this activity.

For information about the Society of Surgical Oncology’s privacy policy and associated disclaimer, please visit this site: https://www.surgonc.org/about-sso/privacy-policy/ .

System requirements for this activity can be found by clicking the Help button. For technical support, please contact us at expertED@surgonc.org